---
trial_id: 1548
discovery_date: 2022-07-29 15:03:31.689824
date: 2022-07-29 15:03:31.689824
title: "A Phase II, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study of Subcutaneous Daclizumab in Patients with Active, Relapsing Forms of Multiple Sclerosis"
summary: |
  <p>EudraCT Number: 2005-001567-55<br />Sponsor Protocol Number: DAC-1012<br />Sponsor Name: Protein Design Labs, Inc.<br />Start Date: 2006-06-23<br />Medical condition: This study is performed in patients with relapsing forms of Multiple Sclerosis. Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS), thought ...<br />Disease: <br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001567-55/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001567-55/AT">AT</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001567-55/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001567-55/ES">ES</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-001567-55'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2005-001567-55<br />Sponsor Protocol Number: DAC-1012<br />Sponsor Name: Protein Design Labs, Inc.<br />Start Date: 2006-06-23<br />Medical condition: This study is performed in patients with relapsing forms of Multiple Sclerosis. Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS), thought ...<br />Disease: <br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001567-55/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001567-55/AT">AT</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001567-55/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001567-55/ES">ES</a> (Completed)</p>